NR4A2 and urinary bladder cancer: NR4A2 is highly expressed in several bladder cancer cell lines and activation of the ligand-binding domain of NR4A2 was demonstrated to induce apoptotic pathways and inhibit growth of bladder cancer established in nude mice [19].